GlassScriptPhysician profile
Laura Taylor
NPI 1720515083
$16,546.24
in general payments reported to CMS, 2019-2025
36 companies · $4,676 in 2025
The $4,676 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.50 · 2020: $98.72 · 2021: $292 · 2022: $3,903 · 2023: $4,617 · 2024: $2,872 · 2025: $4,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,773 · Travel and Lodging: $4,216 · Grant: $2,000 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,772.52 |
| Travel and Lodging | $4,216.13 |
| Grant | $2,000.00 |
| Education | $176.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $7,313.09 | 2022-2025 | Titan |
| Boston Scientific Corporation | $6,065.62 | 2019-2025 | General - Erectile Dysfunction, General - Therapies, Ams 700 |
| Rigicon,INC. | $785.95 | 2022-2024 | Rigi10 Malleable Penile Prosthesis, Rigi10 Malleable Penile Prosthesis |
| Olympus America INC. | $303.89 | 2023-2025 | Soltive, Bovie, Itind System |
| Procept Biorobotics Corporation | $242.72 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $192.98 | 2024 | Xtandi |
| Teleflex LLC | $158.48 | 2021-2025 | Barrigel |
| Endo Pharmaceuticals INC. | $145.66 | 2023 | Xiaflex |
| Stryker Corporation | $135.78 | 2025 | 1788 |
| Janssen Biotech, INC. | $127.04 | 2025 | Carvykti, Rybrevant, Erleada |
| Hollister Incorporated | $105.01 | 2021-2023 | Vapro Pocket, Infyna Chic |
| Myriad Genetic Laboratories, INC. | $101.21 | 2024-2025 | Prolaris |
| Antares Pharma, INC. | $100.00 | 2022-2023 | Tlando, Xyosted |
| Palette Life Sciences, INC. | $98.72 | 2020 | |
| Acerus Pharmaceuticals Corporation | $76.43 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $73.49 | 2022-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $66.17 | 2024-2025 | Orgovyx, Gemtesa |
| Edap Technomed INC | $45.17 | 2025 | |
| Dendreon Pharmaceuticals LLC | $39.54 | 2024-2025 | Provenge |
| Endo USA, INC. | $36.95 | 2025 | Xiaflex, Aveed |
| Telix Pharmaceuticals | $34.21 | 2024 | Illuccix |
| Convatec INC. | $27.17 | 2023 | |
| Davol INC. | $24.58 | 2025 | Arista |
| Organogenesis INC. | $24.47 | 2023 | Puraply |
| Bioprotect Medical, INC. | $23.82 | 2025 | Bioprotect Balloon Implant System |
| Sanara Medtech INC. | $21.34 | 2025 | Biasurge |
| Immunitybio, INC. | $20.55 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.51 | 2025 | |
| Photocure INC | $18.14 | 2019 | |
| Blue Earth Diagnostics | $17.80 | 2025 | Posluma |
| Urogen Pharma, INC. | $17.26 | 2024 | |
| Ferring Pharmaceuticals INC. | $17.19 | 2025 | Adstiladrin |
| Dentsply Ih Ab | $16.80 | 2023 | Lofric |
| Ambu INC. | $15.62 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $14.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.